Format

Send to

Choose Destination
J Perinat Med. 2013 Sep 1;41(5):621-3. doi: 10.1515/jpm-2012-0288.

Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy?

Author information

1
Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH, USA. aoconnor@mainegeneral.org

Abstract

AIM:

To determine whether infant gender influences the course of neonatal abstinence syndrome (NAS) following exposure to buprenorphine during pregnancy.

METHODS:

A retrospective cohort study was performed in which maternal and infant data were collected for 46 male and 44 female infants. All infants were born to women enrolled in a buprenorphine treatment program from December 2007 until October 2012. Maternal and infant characteristics and outcomes were compared by infant gender.

RESULTS:

Male infants had a significantly higher mean peak NAS score (10.04 vs. 7.98, P=0.028) and were more likely to require pharmacologic treatment for NAS (39.1% vs. 11.4%, P=0.005).

CONCLUSIONS:

These data indicate that, following exposure to buprenorphine during pregnancy, male infants experience a more severe withdrawal syndrome and are more likely to require pharmacologic treatment for NAS.

PMID:
23612625
DOI:
10.1515/jpm-2012-0288
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Sheridan PubFactory
Loading ...
Support Center